These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20498028)

  • 41. A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola.
    McGann PT; Ferris MG; Ramamurthy U; Santos B; de Oliveira V; Bernardino L; Ware RE
    Am J Hematol; 2013 Dec; 88(12):984-9. PubMed ID: 24038490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Sickle cell disease in French Guiana: assessing 30 years of neonatal screening (1992-2021)].
    Elenga N; Ro V; Mafema Missindu J; Thomas Boizan N; Vaz T; Lucarelli A; Armoudon-Fleret MÉ; Buendé S
    Med Trop Sante Int; 2024 Mar; 4(1):. PubMed ID: 38846113
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neonatal detection of sickle cell disease in metropolitan France. Association française pour le dépistage et la prévention des handicaps de l'enfant (AFDPHE)].
    Galactéros F
    Arch Pediatr; 1996 Oct; 3(10):1026-31. PubMed ID: 8952800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Haemoglobinopathies and newborn haemoglobinopathy screening in Germany.
    Dickerhoff R; Genzel-Boroviczeny O; Kohne E
    J Clin Pathol; 2009 Jan; 62(1):34. PubMed ID: 19103856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Newborn screening follow-up within the lifespan context: Michigan's experience.
    Grigorescu V; Kleyn MJ; Korzeniewski SJ; Young WI; Whitten-Shurney W
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S522-7. PubMed ID: 20331953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Starting neonatal screening for haemoglobinopathies in The Netherlands.
    Giordano PC
    J Clin Pathol; 2009 Jan; 62(1):18-21. PubMed ID: 19103852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Universal newborn hearing screening: a 27-month experience in the French region of Champagne-Ardenne.
    Lévêque M; Schmidt P; Leroux B; Danvin JB; Langagne T; Labrousse M; Chays A
    Acta Paediatr; 2007 Aug; 96(8):1150-4. PubMed ID: 17578491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Evidence for the widespread use of neonatal screening for sickle cell disease].
    Cavazzana M; Stanislas A; Rémus C; Duwez P; Renoult J; Cretet J; Fernandes S; Le Mée C; Allaf B; Porquet D; Munnich A; Polak M; Gauthereau V; Girot R
    Med Sci (Paris); 2018 Apr; 34(4):309-311. PubMed ID: 29658472
    [No Abstract]   [Full Text] [Related]  

  • 49. [Mass neonatal screening using biological testing].
    Ardaillou R; Le Gall JY;
    Gynecol Obstet Fertil; 2007 Apr; 35(4):367-74. PubMed ID: 17400505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sickle cell disease: screening and management in newborns and infants. Agency for Health Care Policy and Research.
    Smith JA; Kinney TR
    Am Fam Physician; 1993 Jul; 48(1):95-102. PubMed ID: 8322648
    [No Abstract]   [Full Text] [Related]  

  • 51. An evaluation of the Sebia capillarys Neonat Haemoglobin FAST™ system for routine newborn screening for sickle cell disease.
    Murray C; Hall SK; Griffiths P
    Int J Lab Hematol; 2011 Oct; 33(5):533-9. PubMed ID: 21535479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.
    Kavanagh PL; Wang CJ; Therrell BL; Sprinz PG; Bauchner H
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):15-22. PubMed ID: 18200513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Newborn hemoglobinopathy screening in Tennessee--current status.
    Wang WC
    J Tenn Med Assoc; 1989 Sep; 82(9):473-6. PubMed ID: 2796334
    [No Abstract]   [Full Text] [Related]  

  • 54. The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area).
    Grosse R; Lukacs Z; Cobos PN; Oyen F; Ehmen C; Muntau B; Timmann C; Noack B
    Pediatr Blood Cancer; 2016 Jan; 63(1):168-70. PubMed ID: 26275168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.
    Nguyen-Khoa T; Mine L; Allaf B; Ribeil JA; Remus C; Stanislas A; Gauthereau V; Enouz S; Kim JS; Yang X; Gluckman E; Beaudeux JL; Munnich A; Girot R; Cavazzana M
    Ann Biol Clin (Paris); 2018 Aug; 76(4):416-420. PubMed ID: 29976532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sickle cell disease in heel injection screening. II].
    Vansenne F; de Borgie CA; Bouva MJ; Legdeur MA; van Zwieten R; Petrij F; Peters M
    Ned Tijdschr Geneeskd; 2009 May; 153(18):858-61. PubMed ID: 19475864
    [No Abstract]   [Full Text] [Related]  

  • 57. Saudi newborn screening: a national public health program: needs, costs, and challenges.
    Al-Awamy BH
    Saudi Med J; 2008 Mar; 29(3):470; author reply 470. PubMed ID: 18327387
    [No Abstract]   [Full Text] [Related]  

  • 58. A Paper-Based Test for Screening Newborns for Sickle Cell Disease.
    Piety NZ; George A; Serrano S; Lanzi MR; Patel PR; Noli MP; Kahan S; Nirenberg D; Camanda JF; Airewele G; Shevkoplyas SS
    Sci Rep; 2017 Apr; 7():45488. PubMed ID: 28367971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.
    Peters M; Fijnvandraat K; van den Tweel XW; Garre FG; Giordano PC; van Wouwe JP; Pereira RR; Verkerk PH
    Arch Dis Child; 2010 Oct; 95(10):822-5. PubMed ID: 20576657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The potential of electrospray ionization mass spectrometry for the diagnosis of hemoglobin variants found in newborn screening.
    Wild BJ; Green BN; Stephens AD
    Blood Cells Mol Dis; 2004; 33(3):308-17. PubMed ID: 15528150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.